Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease

21 Feb 2019

Abstract excerpt

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression-and Epstein-Barr virus-associated lymphoproliferative disease

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CNS Lymphoma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30792197
DOI: 10.3324/haematol.2018.207548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative diseasePMID 30792197Read ↗

Epstein‐Barr virus post‐transplant lymphoproliferative disease ( PTLD ) after hematopoietic stem cell transplantationSemantic proximity Read ↗

Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatmentSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated DisordersSemantic proximity Read ↗

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTSemantic proximity Read ↗

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell TherapySemantic proximity Read ↗

EPSTEIN-BARR VIRUS-NEGATIVE LYMPHOPROLIFERATIVE DISORDERS IN LONG-TERM SURVIVORS AFTER HEART, KIDNEY, AND LIVER TRANSPLANT1Semantic proximity Read ↗

Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.Semantic proximity Read ↗

Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter studySemantic proximity Read ↗

Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiencySemantic proximity Read ↗

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.